Abnormal expression of laminin chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy

Mian Li, Dennis W. Dickson, Alfred J. Spiro

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Laminin 2 is a major component of the basal lamina of skeletal muscle cells. It is a heterotrimer composed of 3 chains: merosin (laminin α2 chain), β1 and χ1. Deficiency of merosin, with or without laminin β1 chain reduction, is associated with some forms of congenital muscular dystrophy. Deficient expression of laminin β1 chain is also associated with some eases of merosin-positive congenital muscular dystrophy. The expression of laminin 2 subunits has not been well studied in the skeletal muscle of limb-girdle muscular dystrophy (LGMD), not has much attention been given to the significance of reduction of individual laminin 2 subunits such as β1. To examine the expression of laminin 2 subunit in skeletal muscle in patients with LGMD and to define the clinical features of patients with LGMD who have abnormal expression of laminin 2 subunits. Methods: We studied muscle biopsy specimens from 18 patients with LGMD using immunofluorescence with antibodies against dystrophin C-terminus, β- dystroglycan, α-sarcoglycan, χ-sarcoglycan, and the laminin subunits merosin, β1, and χ1. Of the 18 biopsy specimens, 9 were available for electron microscopic examination of the muscle basement membrane. The clinical features associated with abnormal laminin β1 chain immunoreactivity were further described. Results: Laminin β1 chain was either barely detectable or severely reduced in 3 cases of patients with LGMD in which the biopsy specimens showed normal staining with the other antibodies. Patients in all 3 cases had common clinical features consistent with a slowly progressive, adult-onset LGMD. Specimens from 2 of the 3 cases that were available for ultrastructural examination showed significant abnormalities of the muscle fiber basement membrane. Conclusions: Abnormal expression of laminin β1 chain without concomitant deficiency of α- sarcoglycan in skeletal muscle has not been previously described in LGMD. Reduced laminin β1 chain immunoreactivity may potentially serve as a marker for defining subsets of individuals with LGMD, in particular those with slowly progressive, adult-onset pelvifemoral presentation. The abnormality of muscle fiber basement membranes in specimens from cases that were available for ultrastructural study suggests that defects in the extracellular matrix may play a role in the pathogenesis of this subset of LGMD.

Original languageEnglish (US)
Pages (from-to)1457-1461
Number of pages5
JournalArchives of Neurology
Volume54
Issue number12
StatePublished - Dec 1997

Fingerprint

Limb-Girdle Muscular Dystrophies
Laminin
Skeletal Muscle
Sarcoglycans
Basement Membrane
Muscles
Biopsy
Onset
Dystroglycans
Dystrophin
Antibodies
Muscular Dystrophies
Muscle Cells
Fluorescent Antibody Technique
Extracellular Matrix
laminin 1
Membrane

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Abnormal expression of laminin chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy. / Li, Mian; Dickson, Dennis W.; Spiro, Alfred J.

In: Archives of Neurology, Vol. 54, No. 12, 12.1997, p. 1457-1461.

Research output: Contribution to journalArticle

Li, Mian ; Dickson, Dennis W. ; Spiro, Alfred J. / Abnormal expression of laminin chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy. In: Archives of Neurology. 1997 ; Vol. 54, No. 12. pp. 1457-1461.
@article{d802846779cc4329b556e5afe3724f0b,
title = "Abnormal expression of laminin chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy",
abstract = "Background: Laminin 2 is a major component of the basal lamina of skeletal muscle cells. It is a heterotrimer composed of 3 chains: merosin (laminin α2 chain), β1 and χ1. Deficiency of merosin, with or without laminin β1 chain reduction, is associated with some forms of congenital muscular dystrophy. Deficient expression of laminin β1 chain is also associated with some eases of merosin-positive congenital muscular dystrophy. The expression of laminin 2 subunits has not been well studied in the skeletal muscle of limb-girdle muscular dystrophy (LGMD), not has much attention been given to the significance of reduction of individual laminin 2 subunits such as β1. To examine the expression of laminin 2 subunit in skeletal muscle in patients with LGMD and to define the clinical features of patients with LGMD who have abnormal expression of laminin 2 subunits. Methods: We studied muscle biopsy specimens from 18 patients with LGMD using immunofluorescence with antibodies against dystrophin C-terminus, β- dystroglycan, α-sarcoglycan, χ-sarcoglycan, and the laminin subunits merosin, β1, and χ1. Of the 18 biopsy specimens, 9 were available for electron microscopic examination of the muscle basement membrane. The clinical features associated with abnormal laminin β1 chain immunoreactivity were further described. Results: Laminin β1 chain was either barely detectable or severely reduced in 3 cases of patients with LGMD in which the biopsy specimens showed normal staining with the other antibodies. Patients in all 3 cases had common clinical features consistent with a slowly progressive, adult-onset LGMD. Specimens from 2 of the 3 cases that were available for ultrastructural examination showed significant abnormalities of the muscle fiber basement membrane. Conclusions: Abnormal expression of laminin β1 chain without concomitant deficiency of α- sarcoglycan in skeletal muscle has not been previously described in LGMD. Reduced laminin β1 chain immunoreactivity may potentially serve as a marker for defining subsets of individuals with LGMD, in particular those with slowly progressive, adult-onset pelvifemoral presentation. The abnormality of muscle fiber basement membranes in specimens from cases that were available for ultrastructural study suggests that defects in the extracellular matrix may play a role in the pathogenesis of this subset of LGMD.",
author = "Mian Li and Dickson, {Dennis W.} and Spiro, {Alfred J.}",
year = "1997",
month = "12",
language = "English (US)",
volume = "54",
pages = "1457--1461",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Abnormal expression of laminin chain in skeletal muscle of adult-onset limb-girdle muscular dystrophy

AU - Li, Mian

AU - Dickson, Dennis W.

AU - Spiro, Alfred J.

PY - 1997/12

Y1 - 1997/12

N2 - Background: Laminin 2 is a major component of the basal lamina of skeletal muscle cells. It is a heterotrimer composed of 3 chains: merosin (laminin α2 chain), β1 and χ1. Deficiency of merosin, with or without laminin β1 chain reduction, is associated with some forms of congenital muscular dystrophy. Deficient expression of laminin β1 chain is also associated with some eases of merosin-positive congenital muscular dystrophy. The expression of laminin 2 subunits has not been well studied in the skeletal muscle of limb-girdle muscular dystrophy (LGMD), not has much attention been given to the significance of reduction of individual laminin 2 subunits such as β1. To examine the expression of laminin 2 subunit in skeletal muscle in patients with LGMD and to define the clinical features of patients with LGMD who have abnormal expression of laminin 2 subunits. Methods: We studied muscle biopsy specimens from 18 patients with LGMD using immunofluorescence with antibodies against dystrophin C-terminus, β- dystroglycan, α-sarcoglycan, χ-sarcoglycan, and the laminin subunits merosin, β1, and χ1. Of the 18 biopsy specimens, 9 were available for electron microscopic examination of the muscle basement membrane. The clinical features associated with abnormal laminin β1 chain immunoreactivity were further described. Results: Laminin β1 chain was either barely detectable or severely reduced in 3 cases of patients with LGMD in which the biopsy specimens showed normal staining with the other antibodies. Patients in all 3 cases had common clinical features consistent with a slowly progressive, adult-onset LGMD. Specimens from 2 of the 3 cases that were available for ultrastructural examination showed significant abnormalities of the muscle fiber basement membrane. Conclusions: Abnormal expression of laminin β1 chain without concomitant deficiency of α- sarcoglycan in skeletal muscle has not been previously described in LGMD. Reduced laminin β1 chain immunoreactivity may potentially serve as a marker for defining subsets of individuals with LGMD, in particular those with slowly progressive, adult-onset pelvifemoral presentation. The abnormality of muscle fiber basement membranes in specimens from cases that were available for ultrastructural study suggests that defects in the extracellular matrix may play a role in the pathogenesis of this subset of LGMD.

AB - Background: Laminin 2 is a major component of the basal lamina of skeletal muscle cells. It is a heterotrimer composed of 3 chains: merosin (laminin α2 chain), β1 and χ1. Deficiency of merosin, with or without laminin β1 chain reduction, is associated with some forms of congenital muscular dystrophy. Deficient expression of laminin β1 chain is also associated with some eases of merosin-positive congenital muscular dystrophy. The expression of laminin 2 subunits has not been well studied in the skeletal muscle of limb-girdle muscular dystrophy (LGMD), not has much attention been given to the significance of reduction of individual laminin 2 subunits such as β1. To examine the expression of laminin 2 subunit in skeletal muscle in patients with LGMD and to define the clinical features of patients with LGMD who have abnormal expression of laminin 2 subunits. Methods: We studied muscle biopsy specimens from 18 patients with LGMD using immunofluorescence with antibodies against dystrophin C-terminus, β- dystroglycan, α-sarcoglycan, χ-sarcoglycan, and the laminin subunits merosin, β1, and χ1. Of the 18 biopsy specimens, 9 were available for electron microscopic examination of the muscle basement membrane. The clinical features associated with abnormal laminin β1 chain immunoreactivity were further described. Results: Laminin β1 chain was either barely detectable or severely reduced in 3 cases of patients with LGMD in which the biopsy specimens showed normal staining with the other antibodies. Patients in all 3 cases had common clinical features consistent with a slowly progressive, adult-onset LGMD. Specimens from 2 of the 3 cases that were available for ultrastructural examination showed significant abnormalities of the muscle fiber basement membrane. Conclusions: Abnormal expression of laminin β1 chain without concomitant deficiency of α- sarcoglycan in skeletal muscle has not been previously described in LGMD. Reduced laminin β1 chain immunoreactivity may potentially serve as a marker for defining subsets of individuals with LGMD, in particular those with slowly progressive, adult-onset pelvifemoral presentation. The abnormality of muscle fiber basement membranes in specimens from cases that were available for ultrastructural study suggests that defects in the extracellular matrix may play a role in the pathogenesis of this subset of LGMD.

UR - http://www.scopus.com/inward/record.url?scp=0030810062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030810062&partnerID=8YFLogxK

M3 - Article

C2 - 9400354

AN - SCOPUS:0030810062

VL - 54

SP - 1457

EP - 1461

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 12

ER -